York et al. reported that the expression of Siglec-1, an IFN-regulated marker, in circulating monocytes from early SSc and the number of Siglec-1+ cells in skin samples from early SSc were increased compared with healthy controls (HC) (23). Here, IFNA1 is linked to systemic sclerosis.